News | April 01, 2022
Oragnon enters global licencing agreement with Dare Biosciences
An estimated 21 million American women experience BV
An estimated 21 million American women experience BV
World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
The transaction as well as the open offer is expected to be completed by June this year.
The companies plan to use the proceeds to retire debt and expand operations
Subscribe To Our Newsletter & Stay Updated
